高血压急症

Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-248.全文  摘要

Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000 Jul 29;356(9227):411-7. 摘要

1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-248.全文  摘要

2. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. March 2022 [internet publication].全文

3. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016 Aug 9;134(6):441-50.全文  摘要

4. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005 Jan 15-21;365(9455):217-23. 摘要

5. Bloch MJ. Worldwide prevalence of hypertension exceeds 1.3 billion. J Am Soc Hypertens. 2016 Oct;10(10):753-4.全文  摘要

6. Martin JF, Higashiama E, Garcia E, et al. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol. 2004 Aug;83(2):131-6.全文  摘要

7. Deshmukh A, Kumar G, Kumar N, et al. Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol. 2011 Sep 3;108(9):1277-82.全文  摘要

8. Alshami A, Romero C, Avila A, et al. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018 Jul;15(7):504-12.全文  摘要

9. Waldron FA, Benenson I, Jones-Dillon SA, et al. Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community. Blood Press. 2019 Jan 22;28(2):114-23. 摘要

10. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States [published correction appears in N Engl J Med. 2002 Feb 14;346(7):544]. N Engl J Med. 2001 Aug 16;345(7):479-86.全文  摘要

11. Tisdale JE, Huang MB, Borzak S, et al. Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract. 2004 Aug;21(4):420-4.全文  摘要

12. Shea S, Misra D, Ehrlich MH, et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992 Sep 10;327(11):776-81. 摘要

13. Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases. Am J Public Health. 1988 Jun;78(6):636-40.全文  摘要

14. Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens. 1994 Nov;12(11):1297-305. 摘要

15. Guerin C, Gonthier R, Berthoux FC. Long-term prognosis in malignant or accelerated hypertension. Nephrol Dial Transplant. 1988;3(1):33-7. 摘要

16. Davis TK, Halabi CM, Siefken P, et al. Aggressive blood pressure control for chronic kidney disease unmasks moyamoya! Clin Kidney J. 2013 Oct;6(5):495-9.全文  摘要

17. Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis. 2015 Mar;22(2):116-22.全文  摘要

18. Macedo TA, Drager LF, Pedrosa RP, et al. Intermittent claudication and severe renal artery stenosis are independently associated in hypertensive patients referred for renal arteriography. Clinics (Sao Paulo). 2017 Jul;72(7):411-4.全文  摘要

19. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004 Jun;43(6):1071-81. 摘要

20. Chen W, Kayler LK, Zand MS, et al. Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy. Clin Kidney J. 2015 Feb;8(1):71-8.全文  摘要

21. Suneja M, Sanders ML. Hypertensive emergency. Med Clin North Am. 2017 May;101(3):465-78. 摘要

22. Phillips CL, O'Driscoll DM. Hypertension and obstructive sleep apnea. Nat Sci Sleep. 2013 May 10;5:43-52.全文  摘要

23. Silaruks S, Sawanyawisuth K. A case of obstructive sleep apnoea presented with hypertensive emergency. Heart Lung Circ. 2015;24(suppl 3):S121.

24. Whitworth JA, Mangos GJ, Kelley JJ. Hypertension in Cushing’s syndrome. In: Mansoor GA, ed. Secondary hypertension, clinical presentation, diagnosis, and treatment. Totowa, NJ: Humana Press; 2004.

25. Pappachan JM, Buch HN. Endocrine hypertension: a practical approach. Adv Exp Med Biol. 2017;956:215-37. 摘要

26. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42. 摘要

27. Garg MK, Kharb S, Brar KS, et al. Medical management of pheochromocytoma: role of the endocrinologist. Indian J Endocrinol Metab. 2011 Oct;15(suppl 4):S329-36.全文  摘要

28. Kaplan NM. Kaplan's clinical hypertension, 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.

29. Zampaglione B, Pascale C, Marchisio M, et al. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension. 1996 Jan;27(1):144-7.全文  摘要

30. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000 Jul 29;356(9227):411-7. 摘要

31. Marik PE, Varon J. Hypertensive crises: challenges and management [published correction appears in Chest. 2007 Nov;132(5):1721]. Chest. 2007 Jun;131(6):1949-62.全文  摘要

32. Ault MJ, Ellrodt AG. Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med. 1985 Dec;3(6 suppl):10-5. 摘要

33. Luft FC, Mervaala E, Müller DN, et al. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension. 1999 Jan;33(1 Pt 2):212-8.全文  摘要

34. Taylor DA. Hypertensive crisis: a review of pathophysiology and treatment. Crit Care Nurs Clin North Am. 2015 Dec;27(4):439-47. 摘要

35. Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001 Nov;14(11 Pt 1):1154-67. 摘要

36. Kettritz R, Luft FC. Severe hypertension with large-vessel arteritis. Hypertension. 2012 Feb;59(2):179-83.全文  摘要

37. Denton CP, Lapadula G, Mouthon L, et al. Renal complications and scleroderma renal crisis. Rheumatology (Oxford). 2009 Jun;48 (suppl 3):iii32-5. 摘要

38. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2006 Dec 11;49(1):69-75.全文  摘要

39. Fryar CD, Ostchega Y, Hales CM, et al. Hypertension prevalence and control among adults: United States, 2015-2016. NCHS Data Brief. 2017 Oct;(289):1-8.全文  摘要

40. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-104.全文  摘要

41. Bossone E, Rampoldi V, Nienaber CA, et al. Usefulness of pulse deficit to predict in-hospital complications and mortality in patients with acute type A aortic dissection. Am J Cardiol. 2002 Apr 1;89(7):851-5. 摘要

42. Ranasinghe AM, Strong D, Boland B, et al. Acute aortic dissection. BMJ. 2011 Jul 29;343:d4487. 摘要

43. Fuchs FD. Study of the usefulness of optic fundi examination on patients with hypertension in a clinical setting. J Hum Hypertens. 1995 Jul;9(7):547-51. 摘要

44. Van den Born BJH, Honnebier UPF, Koopmans RP, et al. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension. 2005 Feb;45(2):246-51.全文  摘要

45. Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000 Feb 16;283(7):897-903.全文  摘要

46. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993 Jan 7;328(1):1-9.全文  摘要

47. Shiga T, Wajima Z, Apfel CC, et al. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med. 2006 Jul 10;166(13):1350-6.全文  摘要

48. Moore AG, Eagle KA, Bruckman D, et al. Choice of computed tomography, transesophageal echocardiography, magnetic resonance imaging, and aortography in acute aortic dissection: International Registry of Acute Aortic Dissection (IRAD). Am J Cardiol. 2002 May 15;89(10):1235-8. 摘要

49. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.全文  摘要

50. Martin JF, Higashiama E, Garcia E, et al. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol. 2004;83:131-136.全文  摘要

51. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.全文  摘要

52. Elliott WJ. Clinical features and management of selected hypertensive emergencies. J Clin Hypertens (Greenwich). 2004 Oct;6(10):587-92.全文  摘要

53. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015 May 28;46(7):2032-60.全文  摘要

54. Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013 May 29;368(25):2355-65.全文  摘要

55. Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016 Jun 8;375(11):1033-43.全文  摘要

56. van den Born BH, Lip GYH, Brguljan-Hitij J, et al. ESC council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):37-46. 摘要

57. Peacock WF, Varon J, Baumann BM, et al. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care. 2011;15(3):R157.全文  摘要

58. Kondo T, Brock M, Bach H. Effect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulation. Jpn Heart J. 1984 Mar;25(2):231-7. 摘要

59. Griswold WR, Reznik V, Mendoza SA. Nitroprusside-induced intracranial hypertension. JAMA. 1981 Dec 11;246(23):2679-80. 摘要

60. Anile C, Zanghi F, Bracali A, et al. Sodium nitroprusside and intracranial pressure. Acta Neurochir (Wien). 1981;58(3-4):203-11. 摘要

61. Tumlin JA, Dunbar LM, Oparil S, et al. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Acad Emerg Med. 2000 Jun;7(6):653-62. 摘要

62. Devlin JW, Seta ML, Kanji S, Somerville AL. Fenoldopam versus nitroprusside for the treatment of hypertensive emergency. Ann Pharmacother. 2004 May;38(5):755-9. 摘要

63. Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev. 2014 Oct 28;(10):CD000039.全文  摘要

64. Neutel JM, Smith DHG, Wallin D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens. 1994 Jul;7(7 Pt 1):623-8. 摘要

65. Allison TA, Bowman S, Gulbis BJ, et al. Comparison of clevidipine and nicardipine for acute blood pressure reduction in patients with stroke. Intensive Care Med. 2019 Nov-Dec;34(11-12):990-5. 摘要

66. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B. Cumulative meta-analysis of therapeutic trials for MI. N Engl J Med. 1992 Jul 23;327(4):248-54. 摘要

67. Bussmann WD, Kenedi P, von Mengden HJ, et al. Comparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertension. Clin Investig. 1992 Dec;70(12):1085-8. 摘要

68. Erbel R, Alfonso F, Boileau C, et al. Diagnosis and management of aortic dissection. Eur Heart J. 2001 Sep;22(18):1642-81. 摘要

69. Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003 Oct 25;327(7421):955-60.全文  摘要

70. Mabie WC, Gonzalez AR, Sibai BM, et al. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987 Sep;70(3 Pt 1):328-33. 摘要

71. Elatrous S, Nouira S, Ouanes Besbes L, et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Med. 2002 Sep;28(9):1281-6. 摘要

72. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. June 2019 [internet publication].全文

73. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2019 Feb;133(2):e174-80.全文  摘要

74. Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015 Jan 29;372(5):407-17.全文  摘要

75. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019 Jan;133(1):e1-25.全文  摘要

76. US Food and Drug Administration. Drug safety communication: FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. May 2013 [internet publication].全文

77. Medicines and Healthcare products Regulatory Agency. Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy. May 2019 [internet publication].全文

78. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.全文  摘要

79. Bernardes TP, Zwertbroek EF, Broekhuijsen K, et al. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis. Ultrasound Obstet Gynecol. 2019 Apr;53(4):443-53.全文  摘要

80. Bailey JM, Lu W, Levy JH, et al. Clevidipine: a unique agent for the critical care practitioner. Crit Care Shock. 2006;9:9-15.

81. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. 1995 Aug;13(8):915-24. 摘要

82. Webster J, Petrie JC, Jeffers TA, et al. Accelerated hypertension patterns or mortality and clinical factors affecting outcome in treated patients. Q J Med. 1993 Aug;86(8):485-93. 摘要

83. Midgley JP, Matthew AG, Greenwood CM, et al. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996 May 22-29;275(20):1590-7. 摘要

84. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006 Jul 4;114(1):82-96.全文  摘要